NIH-funded research R01 grant

Investigating how liver cells communicate in alcoholic liver disease

Official title: Hepatocyte-derived extracellular vesicles in alcoholic liver disease

Funded at University of California, San Diego · NIH-10816603 · Data updated 2026-11-12

This study is looking at how liver cells talk to immune cells when someone has alcoholic liver disease, by checking how tiny signals from damaged liver cells might affect liver health, with the hope of finding new ways to help treat this condition.

More Alcoholic Liver Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startJuly 1, 2020
Project endMarch 31, 2026
Funding year2024
Award (this year)$581,327
NIH project number5R01AA028134-05
Project IDNIH-10816603 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a history of alcohol consumption who are experiencing liver-related issues, such as fatty liver or inflammation.

Less likely to help

Patients who do not consume alcohol or have liver disease unrelated to alcohol may not benefit from this research.

What this research studies

This research focuses on understanding the communication between liver cells and other immune cells in the context of alcoholic liver disease (ALD). It examines how damaged liver cells release small vesicles that carry important molecular signals, which may influence the progression of liver damage. By studying these interactions, the research aims to uncover the mechanisms that lead to severe liver conditions, potentially paving the way for new treatments. The approach involves analyzing blood samples from models of ALD to track these vesicles and their effects on other cells.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for preventing or treating alcoholic liver disease.

How similar studies have gone: Previous research has shown promising results in understanding cell communication in liver diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Feldstein, Ariel — University of California, San Diego
  • Study coordinator: Feldstein, Ariel

Related research

Other NIH-funded projects on the same topics.

  • Microbiome and Innate Immune Response in Alcohol-Related Liver Disease

    Researchers are studying how gut bacteria and the body's first-line immune defenses contribute to liver damage from alcohol, with a focus on how a specific bacteria and its toxins affect disease severity.

    NIH research University of California, San Diego · La Jolla, United States · NIH-11543368

  • Lipotoxicity and Alcohol-Related Liver Disease

    This project studies how fatty acids cause liver cell damage in alcohol-related liver disease to help develop new treatments.

    NIH research University of North Carolina Greensboro · Greensboro, United States · NIH-11450399

  • NNMT as a Target to Treat Alcoholic Liver Disease

    A study to see if blocking an enzyme called NNMT can help people with alcoholic liver disease.

    NIH research University of Illinois at Chicago · Chicago, UNITED STATES · NIH-11380807

  • How gut fungi may drive alcohol-related liver damage

    Researchers are looking at whether specific fungi in the gut make liver damage from heavy drinking worse in people with alcohol-related liver disease.

    NIH research University of California, San Diego · La Jolla, United States · NIH-11378956

  • Heat shock protein 90 and alcohol-related liver disease: how macrophages fuel inflammation

    This project looks at how a cellular stress protein, HSP90, affects liver inflammation in people with alcohol-related liver disease by focusing on macrophages.

    NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11374847

  • Why alcohol-related liver disease can come back after a transplant

    Looking at whether an enzyme called CerS6 helps fat build up in the liver and whether measuring CerS6 can help detect or predict return of alcohol-related liver disease before or after a liver transplant.

    NIH research University of Washington · Seattle, United States · NIH-11329541

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.